ATF3 and ischemic stroke: Hence, in vivo and in vitro experiments were conducted to investigate whether silencing ATF3 affected mitochondrial homeostasis and ischemic stroke development via the MAPK signaling pathway using the MAPK pathway agonist anisomycin.